According to Aurobindo Pharma
's latest financial reports the company has a price-to-book ratio of 2.27.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.25 | 127.13% |
2022-12-31 | 0.9902 | -46.03% |
2021-12-31 | 1.83 | -38.26% |
2020-12-31 | 2.97 | 70.63% |
2019-12-31 | 1.74 | -49.25% |
2018-12-31 | 3.43 | -10.78% |
2017-12-31 | 3.85 | -15.6% |
2016-12-31 | 4.56 | -45.47% |
2015-12-31 | 8.36 | 20.16% |
2014-12-31 | 6.96 | 76.33% |
2013-12-31 | 3.94 | 80.95% |
2012-12-31 | 2.18 |